Clinical trial
Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme
NCT00010036 · NYU Langone Health, Other · Completed
Key facts
| NCT number | NCT00010036 |
|---|---|
| Title | Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme |
| Official title | A Phase I/II Trial of CPT-11 With Carboplatin in Patients With Glioblastoma Multiforme Prior to Radiation Therapy |
| Lead sponsor | NYU Langone Health, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Radiation |
| Interventions | carboplatin, irinotecan hydrochloride, radiation therapy |
| Start date | May 1, 1999 |
| Primary completion | Oct 1, 2001 |
| First posted | Sep 4, 2003 |
| Last update posted | Mar 28, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: